tigaR: integrative significance analysis of temporal differential gene expression induced by genomic abnormalities by Viktorian Miok et al.
Miok et al. BMC Bioinformatics 2014, 15:327
http://www.biomedcentral.com/1471-2105/15/327
METHODOLOGY ARTICLE Open Access
tigaR: integrative significance analysis of
temporal differential gene expression induced
by genomic abnormalities
Viktorian Miok1,2, Saskia M Wilting2, Mark A van de Wiel1,3, Annelieke Jaspers2, Paula I van Noort4,
Ruud H Brakenhoff5, Peter JF Snijders2, Renske DM Steenbergen2 and Wessel N van Wieringen1,3*
Abstract
Background: To determine which changes in the host cell genome are crucial for cervical carcinogenesis, a
longitudinal in vitromodel system of HPV-transformed keratinocytes was profiled in a genome-wide manner. Four cell
lines affected with either HPV16 or HPV18 were assayed at 8 sequential time points for gene expression (mRNA) and
gene copy number (DNA) using high-resolution microarrays. Available methods for temporal differential expression
analysis are not designed for integrative genomic studies.
Results: Here, we present a method that allows for the identification of differential gene expression associated with
DNA copy number changes over time. The temporal variation in gene expression is described by a generalized linear
mixed model employing low-rank thin-plate splines. Model parameters are estimated with an empirical Bayes
procedure, which exploits integrated nested Laplace approximation for fast computation. Iteratively, posteriors of
hyperparameters and model parameters are estimated. The empirical Bayes procedure shrinks multiple
dispersion-related parameters. Shrinkage leads to more stable estimates of the model parameters, better control of
false positives and improvement of reproducibility. In addition, to make estimates of the DNA copy number more
stable, model parameters are also estimated in a multivariate way using triplets of features, imposing a spatial prior for
the copy number effect.
Conclusion: With the proposed method for analysis of time-course multilevel molecular data, more profound insight
may be gained through the identification of temporal differential expression induced by DNA copy number
abnormalities. In particular, in the analysis of an integrative oncogenomics study with a time-course set-up our
method finds genes previously reported to be involved in cervical carcinogenesis. Furthermore, the proposed method
yields improvements in sensitivity, specificity and reproducibility compared to existing methods. Finally, the proposed
method is able to handle count (RNAseq) data from time course experiments as is shown on a real data set.
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Background
Cervical cancer is caused by infection with high-risk
types of the human papillomavirus (HPV) followed by
additional changes in the host cell genome. Insight in
genes that are consistently altered over time will improve
our understanding of the molecular mechanisms driving
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cervical carcinogenesis. These genes may provide novel
biomarkers for early detection of cervical cancer as
well as potential therapeutic targets. High-throughput
techniques, such as microarrays and next generation
sequencing, are tools for fast high-resolution genome-
wide molecular profiling. Applying these techniques
to measure genes at consecutive moments in time at
multiple molecular levels generates a description of the
occurrence of molecular abnormalities during cervical
carcinogenesis.
A longitudinal in vitro system of four indepen-
dent cell lines immortalized with either HPV16 or
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HPV18, previously shown to faithfully mimic cervical
carcinogenesis at the (epi)genetic level [1-3], was used
in this study. Cell lines were assayed for gene expression
(mRNA) and gene copy number (DNA) with microar-
rays at consecutivemoments in time, representing distinct
stages of transformation. Abnormalities in DNA copy
number were previously shown to directly affect expres-
sion of the genes located within these abnormalities and
are believed to facilitate the identification of functionally
relevant gene expression changes [4]. Integrating these
two molecular levels will yield models of cancer develop-
ment and progression, thereby reducing the complexity
of (cervical) carcinogenesis [5]. We present a method
that, in contrast to existing methods, is able to integrate
DNA copy number and gene expression over time, while
identifying temporal differential gene expression.
Available methods in current literature for time-course
differential gene expression analysis can only be applied to
a single molecular level. Since microarrays have become
widely used for studying genome-wide gene expression,
a range of statistical methods have been tailored for the
identification of differentially expressed genes in microar-
ray time-course experiments. Several of these methods
are developed in an empirical Bayes framework [6-9]. Tai
and Speed [9] usemultivariate empirical Bayes statistics to
rank time-course gene expression profiles. Their method
is applicable to both single-condition and multiple-
condition datasets and includes a variance stabilization
imposing common matrix as a gene-specific variance-
covariance matrix. Alternative approaches involve spline-
based methods which fit a smoothed curve to the
longitudinal data to use for statistical testing [10-12].
Storey et al. [11] use a population average time curve
based on natural cubic splines to capture dynamics in gene
expression levels and employ the F-test to identify signifi-
cant genes. On the other hand, BATS [13] combines these
two: it employs gene-wise functional modelling to explain
temporal differential gene expression, which is casked in a
hierarchical Bayesian framework.
In this article we present a method for identifica-
tion of temporal differential gene expression driven by
genomic abnormalities, introducing several new concepts.
First, employing low-rank thin-plate splines and empiri-
cal Bayes shrinkage, identification of temporal differential
gene expression is improved in terms of sensitivity, speci-
ficity and reproducibility. Second, including DNA copy
number as a time-varying molecular covariate reduces
residual variance and allows for the identification of genes
which have variation in expression over time caused
by genomic abnormalities. Genes with expression levels
affected by DNA copy number aberrations have the capa-
bility to contribute to malignant cell growth [4,14]. Iden-
tification of these genes is therefore essential for a better
understanding of cancer development in general. Third,
we impose a multivariate spatial prior for the DNA copy
number effect to make the estimate more stable, borrow-
ing information from neighboring features. Furthermore,
by changing the link function our method can straightfor-
wardly deal both with continuous and count data. To illus-
trate the wide applicability of our method we applied it
to HPV-induced transformation (microarray) and head &
neck cancer (RNA-seq) data.
Methods
A method for the identification of temporal variation in
gene expression (due to genomic abnormalities) from an
integrative genomics study with a time-course set-up is
presented. The variation in gene expression over time is
described by a generalized linear mixed model employ-
ing low-rank thin-plate splines. Hyperparameters of the
model are estimated from the data with an empirical
Bayes procedure. With parameter estimates at hand, we
describe how relevant hypotheses may be tested. The
section concludes with extensions of the model and prac-
tical considerations for its application.
Model
Consider a time-course microarray experiment where n
cell lines are assayed repeatedly over T consecutive time
points. At each time point both the DNA copy number
andmRNA gene expression of each cell line are measured.
Let the random variables Xi,j,t and Yi,j,t represent the DNA
copy number and the expression level, respectively, of
gene j of cell line i at time point t. Their realizations are
denoted by xi,j,t and yi,j,t . For both random variables the
index j runs from j = 1 to p. This is due to the applica-
tion of a matching procedure [15], which matches probes
from two high-throughput platforms on the basis of their
genomic location.
The expression levels of gene j are assumed to be nor-
mally distributed: Yi,j,t ∼ N (μi,j,t , σ 2ε,j), with σ 2ε,j the error
variance of the expression levels of gene j. The mean of
this distribution is modelled as:
μi,j,t = E
[
Yi,j,t | i, xi,j,t ,αj,βj, γ j
]





where f (·; ·) and h(·; ·)model the fixed and random effects,
respectively, of the expression level of gene j. Both f (·; ·)
and h(·; ·) are specified next.
The fixed effects, encompassing both cell line and DNA





) = αi,j + βj xi,j,t ,
where αi,j is the effect of cell line i in gene j and βj the DNA
copy number effect on the expression levels of gene j.
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The random effect captures the dynamics in the expres-
sion levels over time and is modelled nonparametrically
by low-rank thin-plate splines [16]. These splines provide
enough flexibility for modelling gene expression varia-
tion over time. Furthermore, the low rank approximation
avoids heavy computational costs due to a large number of
unknown parameters. The random effect is thenmodelled
by:
h(t; γ j) =
K∑
k=1
γj,k |t − κk|3 = Ztγ j,
where Zt = (|t − κ1|3, . . . , |t − κK |3) and γ j =
(γj, . . . , γj,K )T, the vector of coefficients of the spline.
These coefficients are randomly distributed as γ j ∼
N (0K×1,γ ,j). The κk , κ1 < κ2 < · · · < κK , are fixed
knots, equally distributed over the interval [ 1, T ].
Model (1) is recasked as a semi-parametric mixed
model. In a mixed model the random effects γj,k
are assumed independent and all stemming from the
same distribution N (0, σ 2γ ,j). Within the context of thin
plate splines this is achieved by assuming a particular
parameterization of γ ,j. This requires the definition of
the matrix  with ()k1,k2 = |κk1 − κk2 |3 for k1, k2 =
1, . . . ,K . Furthermore, let UωDωVTω be the singular value
decomposition of  with Uω and Vω containing its left
and right singular vectors as columns and diagonal matrix
Dω of its singular values. It is then assumed that γ ,j can
be written as VωDωVTω. Under this assumption Model (1)
can be reformulated as the mixed model:
Yi,j,t = αi,j + βj xi,j,t + Z˜t γ˜ j + εi,j,t , (2)
where Z˜t = ZtVωD1/2ω and γ˜ j = D−1/2ω VTωγ j. The inde-
pendent random variables γj,k and εi,j,t of this model are
both multivariately normal with mean zero and covari-
ances Cov(εi1,j,t1 , εi2,j,t2) = σ 2ε only if i1 = i2 and t1 = t2
and zero otherwise, and Var(γ j) = σ 2γ ,jIK×K . The choice
of  results in a covariance matrix with higher covari-
ances of random effects of neighboring knots (than those
of more distant knots).
If we denote withY∗,j,∗ matrix of measurements for gene
jwhich are first ordered by cell lines i and within a cell line
by time. The likelihood for gene j thus is:
L
(













γ j | σ 2γ ,j
)
,
which is to be used in the estimation.
Estimation
The parameters of Model (2) are estimated by means of an
empirical Bayes procedure. Empirical Bayes enables us to
exploit the high-dimensionality of the data by ‘borrowing
information across genes’, which yields more reproducible
results. Information will be shared among genes via com-
mon hyperparameters of the priors of the model parame-
ters. Here this sharing is done only for parameters that will
be subject to inference. Other parameters are considered
confounders that need to be taken into account but are
not of central interest. In principle, our estimation allows
common hyperparameters for these confounders, but at a
computational cost.
For the fixed DNA copy number effect a Dirac-Gaussian
mixture prior (a mixture of a point mass on zero and




) = p0I{βj=0} + (1 − p0)N (βj; 0, τ 2) ,
where N (βj; 0, τ 2) denotes the Gaussian density with
parameters (0, τ 2). The point mass accommodates the
proportion of genes without a DNA copy number effect.
As this proportion is likely to comprise the majority of
genes, it shrinks the βj to zero for those genes with a gene
dosage effect.
The random effect γj,k and error εi,j,t are endowed with
normal priors: N (γj,k ; 0, η2j ) and N (εi,j,t ; 0, ξ2j ). Shrinkage
is applied on the dispersion parameters η2j and ξ2j for
two reasons: a) more stable parameter estimates and b)
protection against over-fitting. The reciprocals of these
parameters, η−2j and ξ−2j , represent precision, for each
a Gamma distribution is used as a conjugate prior. The
parameters a and b of these hyperprior Gamma distribu-
tions are estimated using the method of [17]. The amount
of shrinkage via this prior is determined by the data. The
procedure is initiated with a and b resulting in a very flat
prior on the precision. This corresponds to a very narrow
prior on the variance of the random effect, that is, a flat
spline. Iteratively, should the data give rise to it, the prior
of precision becomes more informative. As a result the
variance moves away from zero, increasing the flexibility
of the spline. Would one desire more shrinkage our pro-
cedure allows the employment of a hyperprior composed
of a Gamma and a point mass at zero.
For the fixed cell line effect αi,j a Gaussian prior is
assumed: N (αi,j;μi,j, ν2j ). No shrinkage (via information
borrowing) is applied to αi,j as it is considered a con-
founder, for which an unbiased estimate is preferred.
We temporarily assume that the cell lines are merely
biological replicates and no inferential statement with
respect to the cell line effect will be made in the
Section ‘Head-and-neck cancer’. Hence, for the moment
the prior of the cell line effect αi,j is N (μi,j, νj). The vari-
ance of this prior depends on index j: the hyperparameter
of this prior is different for each gene.
Given the hyperparameters shared by all genes, the
model parameters of the individual genes are estimated
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by the mean of their posterior distributions. These are
obtained by means of integrated nested Laplace approxi-
mations (INLA) [18]. INLA yields the marginal posterior
distribution of a model parameter through integration
of the posterior distribution over all remaining model
parameters. This can be done computationally efficient
by means of Laplace approximations under the assump-
tion of a Gaussian prior on the model parameters. The
use of approximated posterior distributions (instead of the
possibly more exact posterior produced by Markov chain
Monte Carlo (MCMC)) is motivated computationally:
the posterior distributions of model parameters of many
genes need evaluation.
It remains to choose the hyperparameters. An informed
choice of the hyperparameters is made through applica-
tion of the empirical Bayes procedure of [17]. That is,
the hyperparameters are estimated from the data rather
than set prior to the analysis. Apart from a less sub-
jective choice of the hyperprior, this has two favorable
consequences. First, it yields more reproducible results
(confer the Section ‘Comparison’). Second, the hyperpri-
ors employed cause shrinkage of the model parameter
estimates. In particular, for the random effect it shrinks
the dispersion parameter, which controls the smoothness
of the fit [19]. Hence, it constrains the flexibility of the
spline and thus reduces the risk of overfitting. An illus-
tration of this effect on the fitted spline can be found in
Additional file 1, Section 1.
The conventional empirical Bayesian estimate maxi-

























dαj dβj dσ 2γ ,j, (3)
where π(·) denotes the prior of its argument (hyperpa-
rameters of the priors are suppressed for ease of notation).
The hyperparameters of the priors of the αj, βj, and σ 2γ ,j
are estimated by maximization of loss function (3). Hereto
equate the derivative of (3) with respect to the hyperpa-
rameters to zero and solve. The iterative procedure of [17]
yields an approximate solution to estimating equation (3).
The procedure of [17] is computationally fast and allows
non-parametric hyperpriors.
From expression (3) it becomes clear how the parame-
ter estimates are shrunken. The prior of (say) βj is shared
by all genes. Hence, the choice of the hyperparameters
affects the posterior distribution of all βj. In particular, if
the mass of π(βj) is more concentrated around zero, the
posterior has more probability mass close to zero. Only if
the data contains enough evidence (in favor of a non-zero
βj) to outweigh the prior, the posterior will center around
a non-zero value. The prior of βj puts (via the spike at zero)
more mass at zero. Moreover, the precision of the other
mixture component is estimated from all genes. Under the
assumption that a (vast) majority of genes do not exhibit
an effect, the precision is under-estimated for the minor-
ity. This, together with the spike, yields a conservative
prior leading to shrunken estimates.
Finally, we point out that the procedure described in
[17] assumes covariates to be identical over features. In
our setting the DNA copy number covariate varies over
the features. It would be more appropriate to assume a
different Dirac-Gaussian prior for each group of features
that shares the same aberration pattern over the samples.
These mixture priors differ in the variance of their Gaus-
sian part. This could – in principle – be accommodated by
a mixture of a point mass at zero and a lot of Gaussians,
all with mean zero but different variances. However, a
mixture of Gaussians with the same location but different
variance may be approximated by a t-distribution with
degrees of freedom equal to the number of Gaussians [20].
However, this approximation improves as the number of
Gaussians in the mixture increases. On the other hand, a
t-distribution with many degrees approaches a Gaussian.
As there are usually many different genomic aberration
patterns, we exploit this approximation and assume a
common variance in our Dirac-Gaussian mixture prior. In
a simulation study (Additional file 1, Section 2) we show
that the t-distribution approximation does not differ sub-
stantially from the mixture of Gaussians with common
mean but different variances.
Hypothesis testing
From a biological point two questions are of main interest:
i) does DNA copy number drive gene expression, and ii) is
there differential expression over time? The former ques-
tion can be answered by testing whether the DNA copy
number effect βj differs significantly from zero, evaluat-
ing the null hypothesis H0 : βj = 0 versus its alternative
H0 : βj = 0. The second question is addressed by testing
H0 : σ 2γ ,j = 0 against the alternative HA : σ 2γ ,j > 0. The
alternative implies that there is at least one γj,k = 0,
resulting in a non-constant spline. Additionally, one may
ask whether there is a difference between the cell lines,
but this question is not considered here (although it
could straightforwardly be addressed within the presented
framework).
Both hypotheses are evaluated by means of the likeli-
hood ratio statistic. For the first question on DNA copy
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where e.g. αˆ(HA)j is the estimate of αj under the alterna-
tive hypothesis HA. P-values are then obtained from the
asymptotic (chi-square) distribution of the likelihood ratio
statistics. The degrees of freedom of this chi-square dis-
tribution are equal to the difference in the number of
parameters of the models compared. Note that this test is
likely to be somewhat conservative, because βˆ(HA)j shrinks
towards the null domain. The Dirac-Gaussian mixture
prior, however, prevents overly conservative behavior,
because it better separates the null genes from the non-
null ones than a simple Gaussian prior. When testing
H0 : σ 2γ ,j = 0, the degrees of freedom consumed by the
penalized splines are estimated by the trace of hat matrix
(details: Additional file 1, Section 3). Finally, to account for
multiplicity the False Discovery Rate (FDR) is controlled
by means of the procedure of [21].
This hybrid testing procedure (empirical Bayesian esti-
mation with p-value based inference) mimics Limma
[22,23]. Limma obtains a shrunken (empirical Bayes) esti-
mate of the variance and detects differential expression
using a classical t-test (after adjusting the degrees of free-
dom). Here too we borrow strength (information) across
genes to arrive at shrunken parameter estimates, and
provide classical p-values. The latter meets the wishes
of medical researchers. They commonly report p-values
rather than Bayes factors. In addition, multiple testing
corrections are generally more rigorous in a classical set-
ting than in a Bayesian one, because the latter typically
provides FDR estimation rather than control.
Spatial multivariate prior
DNA copy number aberrations are often not confined
to a single gene but span a large region of the genome
that harbors multiple genes. Consequently, neighboring
genes may share the same genomic aberration signature.
At the transcriptomic level this results in co-expression
of these genes [24]. Put differently, the DNA copy num-
ber effect (βj) of gene j may be correlated with that of
neighboring genes (e.g. βj−1 and βj+1). This phenomenon
is not accommodated by the aforementioned prior of
the βj.
In this section we describe an extension of our pro-
cedure that incorporates the possible spatial correlation
among the DNA copy number effects. To this end it is
assumed that the βj follows a first-order autoregressive
(AR(1)) process along the genome: βj = ρβj−1 + εj. The
relevant parameter of this process is simply estimated by
regression of the βj on the βj−1.
Having obtained an estimate of the spatial correla-
tion among the βj, it rests to refit the model. However,
the assumption of an AR(1) process on the gene dosage
effect complicates the refitting as this should now be
done simultaneously for all p genes. This is computa-
tionally too demanding. To approximate the joint fit the
model is refitted per triplet of neighboring genes (e.g. for
βj−1,βj,βj+1). For each triplet a trivariate normal prior is















σ 2j−1 σj−1σjρ σj−1σj+1ρ2
σj−1σjρ σ 2j σjσj+1ρ





where the correlation structure of the covariance matrix
follows an AR(1) process. For the re-estimated vector of
βjs only the middle one is conserved. More details are
provided in Additional file 1, Section 4.
Besides doing more justice to the underlying biology the
‘spatial prior’ above reduces the variation of the DNA copy
number effect. This is achieved as the assumption of an
AR(1) process effectively ‘averages’ the DNA copy number
effect over neighbouring genes. As such, it is also a way of
borrowing information across genes.
Practical considerations
A straightforward extension of Model (2) is to allow for
a different spline in each cell line. This reflects the bio-
logical plausibility of different dynamical behaviour in
different cell lines. In particular, we may then test for
differences in the behavior over time between the cell
lines. When rewriting Model (2) to a vector notation, the
incorporation of different splines per cell line amounts to
the replacement of Z˜ = Z˜ ⊗ 1n×n by Z˜ = Z˜ ⊗ In×n
(the operator ⊗ is the Kronecker product), and adjusting
the parameter vector γ j accordingly. Figure 1 illustrates
the difference between the same and different spline
models.
Within mixed Model (2) DNA copy number and time
(via the spline) compete to explain the gene expression.
Due to its flexibility the spline may consume variation
in expression levels actually due to DNA copy num-
ber changes. Moreover, with DNA copy number changes
being a more clearly delineated cause (than time in the
form of a nonparametric spline), we prefer to attribute
variation in expression levels to the genomic aberration.
To let DNA copy number changes prevail over the spline,
the design matrix Z of the latter is orthogonalized to
the DNA copy number data. This orthogonalization does
not affect the overall fit, but ensures that the spline cap-
tures only variation in expression levels that cannot be
explained by DNA copy number changes. The effect of
the orthogonalization is illustrated in the Section ‘HPV-
induced transformation’.
To determine the optimal number of knots, we employ
the deviation information criterion (DIC) [25]. The DIC is
a measure for the balance between fit and complexity. For
each gene the DIC of the model is estimated for different
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Figure 1 Illustration of the same and different spline model. Each panel, one per cell line, plots gene expression against time. The solid red
curve represents the fit of the model with a different spline per cell line, while the dashed blue lines depict the fit of the same spline model.
numbers of knots. The number of knots that over all genes
yields the best DIC is chosen as the optimal k and applied
to all genes in the analysis. More details are provided in
Additional file 1, Section 5.
Results and discussion
HPV-induced transformation
The proposed method is demonstrated on data of
an experiment on HPV-induced transformation. The
experiment intends to faithfully mimic cervical cancer
development employing a HPV-immortalized in vitro
cell line model. Hereto two cell lines are affected with
HPV16 and two with HPV18 [26]. Over time these cell
lines acquire genomic and transcriptomic changes. To
assess these changes, the genomic and transcriptomic
characteristics of the cell lines are measured at eight
time points by means of oligonucleotide microarrays.
The preprocessing of the DNA copy number data com-
prises of median normalization and segmentation using
the circular binary segmentation (CBS) method [27].
Similarly, the gene expression data are background cor-
rected using robust multi-array average (RMA) [28] and
between-array normalized by the robust quantile method.
Finally, the resulting expression intensity values are trans-
formed using the variance stabilizing transformation [29].
DNA copy number is assigned to each transcript from
the expression array by the overlapPlus matching
procedure of [15] which uses chromosomal location infor-
mation. The final data set contains genomic and tran-
scriptomic information on 37768 features, however in this
section analysis is performed only on one chromosome
which contains 2202 features.
We now turn to the identification of genes with differen-
tial expression over time. To this end only the expression
data features are used, ignoring the effect of genomic
aberrations in Model (2). Gene j exhibits temporal gene
expression if H0 : σ 2γ ,j = 0 is rejected. This corresponds
to a spline differing from a flat line, and thus indicating
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changes in expression levels over time. Temporal gene
expression is identified both with a common and different
spline(s) for the cell lines. In both analyses the optimal
number of knots equals two (determined by the proce-
dure described in the Section ‘Practical considerations’).
Specification of the prior distribution and description of
the hyperparameter estimations for η2j can be found in the
Section ‘Estimation’.
Table 1 (the first row) shows the number of features
that exhibit significant temporal differential expression at
a 5% false-discovery rate. Considerably more significant
genes are identified when allowing for a different spline
per cell line. This is in line with expectations as it is the
more flexible model. Often it also does more justice to
the biology, as many of its selected genes indeed show dif-
ferent behavior over time among cell lines. The common
spline model may yield a poor fit for these genes, in par-
ticular if there is opposing behavior among the cell lines.
However, the common spline model is effective in identi-
fying genes which are consistently up- or down-regulated
in all cell lines. The model with a common spline found 74
significant features not identified by the model with a dif-
ferent spline per cell line. In the latter analysis these genes
have p-values close to but just short of the significance
threshold.
The common and different spline models employed for
the identification of temporal differential expression are
now extended to include DNA copy number (as originally
proposed in the Section ‘Model’). As noted in the Section
‘Practical considerations’ the flexibility of the spline may
consume part of the DNA copy number effect. The pro-
posed remedy limits (via projection) the spline basis
to the space orthogonal to space spanned by the DNA
copy number information. To assess the potential gain of
the orthogonalization each analysis, with common and
different spline(s), is done with and without orthogonal-
ization. Prior distributions are as before. The number of
knots is determined as done previously (optimal num-
ber still equals two). For each analysis hyperparameters of
DNA copy number and spline(s) are re-estimated by the
empirical Bayes procedure.
Table 1 The number of significant probes identified in the
analysis for temporal differential expression and copy
number (CN) effect
Same spline Different spline
Effect Model Standard Orthogonal Standard Orthogonal
Time
Splines 417 583
CN+Splines 204 203 421 421
CN
CN+Splines 402 403 380 380
Multivariate 398 399 377 380
Analysis is performed only on 2202 features, which represent one chromosome.
We first discuss the number of features with differential
temporal expression (given in the second row of Table 1).
As in the analysis without DNA copy number, the dif-
ferent spline model identifies substantially more features
than the model with a common spline for the cell lines.
Orthogonalization of the (common) spline basis onto the
DNA copy number data misses one feature in compar-
ison to the non-orthogonalized analysis. This feature is
found only with the non-orthogonalized spline basis. In
the latter analysis it only passes the significance thresh-
old by a small margin. Hence, in these data the effect
of orthogonalization on the identification of temporal
differential expression is limited.
Turning to the effect of DNA copy number, we first ana-
lyzed the data with Model (2) containing only the fixed
cell line and DNA copy number effect. This analysis iden-
tified 568 features with a significant gene dosage effect
on expression. Inclusion of the time effect in Model (2)
reduces the number of features with a significant gene
dosage effect on expression (third row of Table 1). This is
due to the fact that the spline competes with DNA copy
number to explain the variation in expression levels: the
former (being more flexible) captures variation caused by
the latter. That aside, here too we see that the improved fit
(now due to the increased flexibility of a different spline
per cell line) yields a surge in the number of findings.
The orthogonalization of the spline basis identify only
one additional feature (using common splines) compared
to the standard analysis. The effect of orthogonaliza-
tion is more visible in the gene dosage effect βj, as can
be witnessed from Figure 2. Clearly, orthogonalization
moves the distribution of the βj’s to the right (the pos-
itive domain, which corroborates with the biologically
expected direction of the effect). Finally, on the full data
set (not shown) the analysis using the orthogonalized
spline basis gives a modest improvement in the number of
genes significantly affected by DNA copy number.
The effect of DNA copy number changes is also ana-
lyzed with the spatial prior discussed in the Section
‘Spatial multivariate prior’. This prior aims to capture
roughly the spatial dependency between consecutive fea-
tures, thus hoping to do more justice to the underlying
biology. Clearly, estimation of the gene dosage effects
with the spatial prior improves the lag one partial cor-
relation among these effects (confer Figure 3). Changes
in the actual parameters are noticeable but small. This
has limited effect on the fit of the model. Consequently,
the significance analysis of the DNA copy number effect
identifies almost the same number of significant features
(fourth row of Table 1). Spatial prior imposed reduces the
variation among contiguous features as, effectively, it has a
smoothing effect on estimated DNA copy number effects.
Figure 4 illustrates the spatial effect by showing the fit of
the model with and without spatial priors on the DNA
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Figure 2 Histograms of DNA copy number parameters. The left panel represents DNA copy number parameters estimated using standard
spline design matrix, while the right panel indicates parameters estimated employing an orthogonalized spline design matrix.
copy number parameter (in Additional file 1, Section 7
illustrates this effect in all four cell lines). As in the tempo-
ral differential expression analysis, the number of features
identified with standard or orthogonal spline basis hardly
differs.
Another striking feature of Table 1 is the differ-
ence between the number of significant features with
differential temporal expression and those with a gene
dosage effect: the former exceeds the latter (in case of
the full model with different splines per cell line). In
Figure 3 Partial correlation of DNA copy number parameter, where βj is plotted against βj+1. In the left panel parameters of DNA copy
number βj are estimated univariate, while in the right panel parameters are estimated multivariate imposing the spatial prior.
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Figure 4 The plot illustrates the effect of the spatial prior for one gene in a single cell line. Gene expression is plotted against time and lines
represent the univariate (red, solid line) and multivariate fit (blue, dashed line).
part this difference is explained by the flexibility of the
splines. But also by the presence of many other regu-
lators of gene expression (e.g. microRNA, methylation,
transcription factors) that result in temporal differen-
tial expression are captured by the splines. On the other
hand, comparing the analyses with a common spline more
significant gene dosage effect than temporal differential
expression is found. This is due to the fact that DNA copy
numbers may strongly correlate with gene expression over
time. Features with expression levels that do not consis-
tently (over cell lines) co-vary with DNA copy number are
missed by the common spline model (and not including
the gene dosage effect).
To give some more tangible insight into the results from
the analyses above, we single out the CADM1 gene. It is
among the genes with the highest significance for tempo-
ral differential expression (using Model (2) with a com-
mon spline). Indeed, CADM1 is down-regulated in all four
cell lines over time (confer Figure 5). This gene is well-
known in cervical cancer to be down-regulated during
progression due to an increasingly methylated promoter
region [1,30]. The fits of Model (2) with and without DNA
copy number hardly differ. The estimate of the DNA copy
number parameter (obtained with the common spline
model) confirms this (βˆCADM1 = 0.1). This suggests that
the down-regulation of CADM1 is not due to a DNA copy
number loss, which corresponds with previous findings
(e.g. [1]).
To contrast the results for CADM1, we focus on the
SLC25A36 gene. SLC25A36 exhibits temporal differen-
tial expression (irrespective of the choice for common or
different spline model). SLC25A36 is also identified as a
gene with a significant DNA copy number effect with esti-
mate βˆSLC25A36 = 1.6. Inclusion of DNA copy number in the
model improves the fit substantially (confer Figure 6, illus-
tration on all four cell lines in Additional file 1, Section 7).
This is seen in Figure 6 as the difference in fit for the
model with and without DNA copy number. These results
for SLC25A36 corroborate with existing medical litera-
ture: the gene dosage effect for this gene has already been
reported in cervical cancer [31].
Finally, we want to assess the sensitivity of the results
with respect to the choice of the prior distribution. For
illustration purposes we focus on the hyperprior of the
random effect γk,j. In the Section ‘Estimation’ we sug-
gest to use the Gamma distribution. However, we have
also implemented a mixture of a point mass at zero and
Gamma distribution, which one expects to lead to more
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Figure 5 Expression levels of CADM1 over time. The solid red and dashed blue lines are the fits of the model with and without DNA copy
number parameter, respectively.
shrinkage. Model (2) using different splines and a stan-
dard design matrix is refitted now with this mixture prior
for the random spline effect. Application of our empirical
Bayes procedure with the Gamma prior identified 421 fea-
tures, while the Dirac-Gamma mixture prior selected 396
features. The latter 396 are all included in the former 421
features. The slight reduction in the number of selected
features is of course due to the inclusion of the point mass
at zero. The fit of both resulting models is almost identical
for most features, but for some features with a slightly less
flexible spline as in Figure 7 (Additional file 1, Section 7
illustrates effect in all four cell lines).
Head-and-neck cancer
To illustrate the wide applicability of our framework, we
present the analysis of sequencing data from a head-and-
neck cancer study endowed with a time-course set-up.
Oshlack et al. [32] noticed that there are currently no
appropriate methods for the analysis of RNA-seq data
from time-course experiments. The head-and-neck study
aims to identify temporal differential expression due to
overexpression of a particular microRNA.MicroRNAs are
small 20-22nt non-coding RNAs that inhibit expression
of their target genes. The microRNAs recognize these
genes by their seed sequence that is complementary to
a sequence in the 3’ untranslated region (UTR) of the
target transcripts. One gene can be targeted by multiple
microRNAs and one microRNA may target a multitude
of genes. It is therefore not simple to find a specific rele-
vant target gene of a microRNA. In a previous functional
screen microRNAs were identified that specifically kill
head and neck cancer cells, but not normal cells [33].
The respective target genes of these microRNAs were to
be identified in a follow-up experiment. In this follow-up
experiment cells of a squamous cell carcinoma cell line
were transfected by amicroRNAmimic and a control. The
transfected cells were grown in vitro and sampled at six
time points. Transcript levels of the 2 × 6 samples were


















Fit with DNA copy number effect Fit without DNA copy numer effect
Figure 6 Expression levels of SLC25A36 over time in a single cell line. The solid red and dashed blue lines are the fits of the model with and
without DNA copy number parameter, respectively.
Figure 7 This plot illustrates the effect of using different priors in one cell line. Gene expression is plotted against time (single cell line only).
The solid red line is the fit of the model with a standard prior, while the dashed blue line is that of the model with an alternative prior.
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sequenced. Data were mapped to the human genome and
raw count data (reads) per gene transcript were used and
not summarized per gene. Their normalization comprises
rescaling by a the trimmed mean of each sample’s library
(following [32]). Normalized data are rounded to the clos-
est integer to retain the count interpretation of the data.
Model (2) cannot be directly applied to the sequencing
data, as the normal distribution is often a poor approxima-
tion for the distribution of counts. The normality assump-
tion is replaced by the (zero-inflated) negative binomial
[17,34]: Yi,j,t ∼ ZI-NB(μi,j,t ,φε,j). The mean μi,j,t of the
counts is (after transformation by the inverse of the link
function) still modeled by the right-hand side of Model (2)
with assumptions on model parameters in place. Hyper-
parameters are then estimated via the empirical Bayes
procedure previously described.
The analysis of the head-and-neck cancer data concen-
trates on two main questions: identification of tags with
temporal variation and those different between the two
conditions. To answer this, Model (2) is used without the
DNA copy number term (which is not included in the
experiment). Common and different spline models are
employed as in the Section ‘HPV-induced transformation’.
Parameter γj is the main parameter of interest and the
analysis compares the model with and without time effect.
The optimal number of knots (again two, for both mod-
els) is determined using the procedure described in the
Section ‘Practical considerations’. Prior distributions for
cell line and time effect are as in the Section ‘Estimation’.
Hyperparameters are estimated for each analysis sepa-
rately, but only the variance of the random time effect is
shrunken via the empirical Bayes procedure. Counts of are
fitted using the model with same and different splines as
illustrated for one RNA-seq tag in Figure 8.
The number of tags with a significant (at the 5% FDR
level) temporal variation identified equals 8416 (10951)
for the common (different) spline model. As observed
in the analysis of the HPV-induced transformation data,
the use of a different spline leads to many more findings.
Again, this is explained by the improved fit due to a
more flexible model. In particular, all the tags identified
with the same spline model are also found by its flexible
counterpart.
Comparison
The proposed method is compared to three well-
known alternatives for significance analysis of time-course
microarray data: EDGE, [11], timecourse, [9], BATS
[13,35], and a reference method. The reference method
comprises a standard frequentist approach. It fits a linear
mixed-effect model, while the null hypothesis is evalu-
ated through an analysis of variance approach (anova),
comparing two nested models (with and without random
effects).
These competitors have not been designed for the
analysis of integrative genomics studies with a time-
course set-up. Hence, our method is applicable to a wider
class of studies. Besides this qualitative argument, we wish
to have a quantitative comparison of the methods. To this
end the comparison is restricted to time-course genomics
studies involving only a single molecular level. Moreover,
to avoid bias of any of the methods by a particular model
choice, the comparison is done on two real data sets.
The first is the HPV-induced transformation data from
the Section ‘HPV-induced transformation’, limited to the
gene expression levels only. The other data set is included
in the EGDE-package [11], where gene expression has
been monitored in four individuals from a control and
endotoxin-treated group. Samples have been collected at
five different time points: 2, 4, 6, 9 and 24 hours after
treatment. One individual lacks data for the control group
at two time points (4 and 6 hours). Since the timecourse
method cannot deal with missing time-points this indi-
vidual is omitted from the analysis. At each time point
expression levels of 800 genes are available.
We now briefly describe the other methods used in the
comparison: EDGE, BATS and timecourse. For a more
detailed description please refer to the corresponding
references.
EDGE ([11]) captures the temporal variation in the
expression levels of gene j by means of a p-dimensional B-
spline basis. Temporal differential expression is evaluated
by an F-statistic measuring the goodness-of-fit of the null
hypothesis (a flat or constant spline) in comparison to the
alternative hypothesis. In the comparison EDGE is used
with default parameter settings.
Method timecourse ([9]) uses novel multivariate
empirical Bayes statistic to rank time-course gene expres-
sion profiles. Gene expression in timecourse method is
assumed to follow a multivariate normal distribution with
gene-specific mean and covariance. Conjugate priors are
assumed on the unknown parameters. Hyperparameters
of the conjugates are estimated from the data. Timecourse
yields stable variance estimates by borrowing (co)variance
information across genes. The posterior distribution and
test statistics are obtained in an analytic form. Genes
may be ranked using either Hotelling T2 orMB-statistics.
For the comparison we used the timecourse R-package
with standard settings and Hotelling T2-statistic, due to
the balancedness of the study design (equal number of
replicates per gene).
Finally, BATS ([13]) which combines characteristics
from previously described methods. Similar to EDGE
gene expression variation over time is modelled by a poly-
nomial function, while imposing a hierarchical Bayesian
model on the parameters (as timecourse). BATS is flexible
in its choice of the prior for dispersion related parameters,
it offers delta, inverse Gamma and exponential priors.
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Figure 8 The dots represent the RNA-seq tag counts plotted against time. The solid (red) line represents the fit of the model with different
splines per group while the dashed (blue) line that of the model with a common spline for both groups.
Significance analysis is based on the genes’ Bayes fac-
tors, while multiplicity correction is addressed in Bayesian
manner ([36]).
Sensitivity and specificity of the four aforementioned
methods are compared in both data sets. Hereto
knowledge of the genes with true temporal differential
expression is needed. In its absence we constructed a
consensus set which fulfills this role. That consensus set
comprises of the features identified by all four methods.
Sensitivity is then the proportion of features with tempo-
ral differential expression correctly identified as such. On
the other hand, specificity is the proportion of features
which are correctly identified as features without differ-
ential expression over time (hence, rightly not significant).
Sensitivity and specificity of each method are assessed for
various numbers of significant features.
Figure 9 presents the resulting sensitivity and speci-
ficity for the HPV-induced transformation data. The left
panel of Figure 9 compares the sensitivity. While BATS,
timecourse and EDGE are more or less on a par, they all
have a lower true positive rate than tigaR. With respect to
the specificity, the methods are more or less on a par with
tigaR having a slightly lower false positive rate than the
other methods. This is confirmed (though much less pro-
nounced) by the results from the EDGE-package data (see
Additional file 1, Section 6). For both sensitivity and speci-
ficity the methods perform similarly with tigaR having a
marginal lead.
Furthermore, we compared the reproducibility of the
five methods (now including reference method). Hereto
each data set was divided into two equally sized groups.
We assessed how well the results of the two splits coin-
cided. This boils down to the application of each method
on both splits. The overlap in significant features for each
method was determined.
Figure 10 shows the reproducibility of each method
on the data set from the Section ‘HPV-induced trans-
formation’. It reveals that BATS and tigaR reproduce


























































Figure 9 Comparison of sensitivity and specificity for tigaR, EDGE, BATS and timecourse on the data set of the Section
‘HPV-induced transformation’. The left (right) panel displays the sensitivity of the methods (specificity) by plotting true (false) positive rate against
the number of significant features.
Figure 10 Reproducibility of tigaR, EDGE, BATS, timecourse and reference model are assessed on the data set of the Section
‘HPV-induced transformation’. The number of significant features identified in both groups are plotted against the initial number of features.
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substantially better than the competitors. This is con-
firmed in the other data set (see Additional file 1, Section
6). The superior reproducibility is most likely a conse-
quence of the empirical Bayes approach (borrowing of
information stabilizes estimates) in tigaR and very infor-
mative priors in BATS. The tigaR, BATS and timecourse-
methods domuch better than EDGE in both data sets. The
former three all exploit the Bayes principle (in different
ways though) which improves estimates of the variance
parameters, while EDGE does not.
Conclusions
We presented a method for the analysis of integra-
tive (onco) genomics studies with a time-course exper-
imental design. The method identifies temporal differ-
ential gene expression while accounting for time-varying
molecular covariates like DNA copy number changes.
Simultaneously, the method assesses which of these
covariates significantly contributes to temporal differ-
ential gene expression. The method employs a mixed
model describing the temporal changes in gene expression
in terms of DNA copy number and a (low-rank thin-
plate) spline which captures additional temporal varia-
tion in the transcript levels. The method estimates the
parameters of this model by means of an empirical Bayes
procedure that ‘borrows information’ across genes. The
empirical Bayesian procedure shrinks the parameter esti-
mates (towards zero), thus accounting for multiplicity.
This shrinkage enhances the reproducibility of the results.
In a direct comparison with other methods for the identi-
fication of temporal differential expression, the proposed
method proved to be a strong competitor, particularly
in terms of reproducibility. In addition existing methods
cannot incorporate additional genomics data. Further-
more, our method is straightforwardly applicable to count
data resulting from RNA-seq experiments. Application
to an integrative oncogenomics study, involving HPV-
transformed cell lines, confirmed genes CADM1 and
SLC25A36, known to be implicated in the development of
cervical cancer. The presented methodology also identi-
fied other, novel and potentially interesting genes. These
are currently under investigation and will be reported in
a follow-up medical paper. Preliminary pathway analysis
already showed that genes identified from this dataset by
tigaR but not by the other methods were enriched for
genes involved in cellular transformation.
Our ongoing research concentrates on two extensions of
the proposed method. First, we are considering the inclu-
sion of microRNA data. MicroRNAs affect expression
levels post-transcriptionally. However, which microRNA
targets which mRNA is only partially known. Hence, inte-
gration of temporal microRNA expression data also needs
to address the problem of selecting the microRNAs tar-
gets.With the number of microRNAs known and typically
measured in time-course integrative genomics studies
being larger than the number of samples (# time points ×
# cell lines) this adds an additional layer of complexity to
the problem.
The second extension comprises the integration of path-
way information. This requires a multivariate formulation
of the model for temporal changes in gene expression.
Next to DNA copy number changes now the changes
in transcript levels of other genes in the pathway may
need to be included. A key challenge here is to ‘borrow
information’ within and between pathways.
The methodology described in this paper is imple-
mented in the R-package tigaR available upon request
from the first author (v.miok@vumc.nl).
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